These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9827291)

  • 1. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 2. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
    Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
    Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
    Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
    Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 8. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine hypersensitivity.
    Popovic M; Shenton JM; Chen J; Baban A; Tharmanathan T; Mannargudi B; Abdulla D; Uetrecht JP
    Handb Exp Pharmacol; 2010; (196):437-51. PubMed ID: 20020271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
    Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
    J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switch study of nevirapine.
    AIDS Patient Care STDS; 2000 Dec; 14(12):672. PubMed ID: 11187109
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 16. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
    Gill S; Sagar A; Shankar S; Nair V
    Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender difference in Nevirapine-associated rash.
    Proj Inf Perspect; 1999 Apr; (27):11. PubMed ID: 11366728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex differences in nevirapine rash.
    Bersoff-Matcha SJ; Miller WC; Aberg JA; van Der Horst C; Hamrick HJ; Powderly WG; Mundy LM
    Clin Infect Dis; 2001 Jan; 32(1):124-9. PubMed ID: 11118391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.